Joseph Pogliano - Concepedia

Concepedia

Author

Joseph Pogliano

University of California San Diego

Also Known As

Joseph A. Pogliano, Joseph Pogliano

26

Publications

1.5K

Citations

17

H-Index

32

Concepts

All Affiliations

University of California San Diego University of California, Los Angeles Wayne State University Eugene Applebaum College of Pharmacy and Health Sciences University of Wisconsin–Madison

JP

About

Joseph Pogliano is an author at University of California San Diego specializing in medicine, clinical microbiology, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	565
2	Health Sciences	5	5	341
3	Microbiology	5	5	393
4	Biochemistry	1	1	63
5	Immunology	1	1	31

Joseph Pogliano

×

19

Publications

1.5K

Citations

17

H-Index

	Year	Citations
SecA membrane cycling at SecYEG is driven by distinct ATP binding and hydrolysis events and is regulated by SecD and SecF Anastassios Economou, Joseph Pogliano, Jonathan Beckwith, Cell	1995	299
Antimicrobial Salvage Therapy for Persistent Staphylococcal Bacteremia Using Daptomycin Plus Ceftaroline George Sakoulas, Pamela Moise, Anthony M. Casapao, Clinical Therapeutics Antimicrobial SusceptibilityAntibioticsAntimicrobial Salvage TherapyAntimicrobial ChemotherapyMicrobiology	2014	179
Ampicillin Enhances Daptomycin- and Cationic Host Defense Peptide-Mediated Killing of Ampicillin- and Vancomycin-Resistant Enterococcus faecium George Sakoulas, Arnold S. Bayer, Joseph Pogliano, Antimicrobial Agents and Chemotherapy	2011	172
Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus George Sakoulas, Cheryl Okumura, Wdee Thienphrapa, Journal of Molecular Medicine InflammationHealth SciencesMedicineInnate ImmunityNafcillin Enhances	2013	141
Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model Brian J. Werth, George Sakoulas, Warren E. Rose, Antimicrobial Agents and Chemotherapy	2012	133
Ceftaroline Restores Daptomycin Activity against Daptomycin-Nonsusceptible Vancomycin-Resistant Enterococcus faecium George Sakoulas, Warren E. Rose, Poochit Nonejuie, Antimicrobial Agents and Chemotherapy	2013	92
Treatment of High-Level Gentamicin-Resistant Enterococcus faecalis Endocarditis with Daptomycin plus Ceftaroline George Sakoulas, Poochit Nonejuie, Victor Nizet, Antimicrobial Agents and Chemotherapy Excellent SynergyAntimicrobial SusceptibilityE. FaecalisHealth SciencesAntibiotic Adjuvant	2013	64
Functional requirements for bacteriophage growth: gene essentiality and expression in mycobacteriophage <scp>G</scp>iles Rebekah M. Dedrick, Laura J. Marinelli, Gerald L. Newton, Molecular Microbiology	2013	64
Penicillin Binding Protein 1 Is Important in the Compensatory Response of Staphylococcus aureus to Daptomycin-Induced Membrane Damage and Is a Potential Target for β-Lactam–Daptomycin Synergy Andrew D. Berti, Erin Theisen, John‐Demian Sauer, Antimicrobial Agents and Chemotherapy Microbial PathogensStaphylococcus AureusMolecular BiologyAntimicrobial ChemotherapyAntibiotic Resistance	2015	63
Heterogeneity of <i>mprF</i> Sequences in Methicillin-Resistant Staphylococcus aureus Clinical Isolates: Role in Cross-Resistance between Daptomycin and Host Defense Antimicrobial Peptides Arnold S. Bayer, Nagendra N. Mishra, George Sakoulas, Antimicrobial Agents and Chemotherapy	2014	62

Page 1